Literature DB >> 19595745

Modulation of thioredoxin reductase-2 expression in EAhy926 cells: implications for endothelial selenoprotein hierarchy.

Michael S Crane1, Alexander F Howie, John R Arthur, Fergus Nicol, Lynne K Crosley, Geoffrey J Beckett.   

Abstract

BACKGROUND: We examined the expression of the mitochondrial selenoenzyme TrxR2 in the endothelial cell line EAhy926 under conditions known to modify its cytoplasmic counterpart TrxR1.
METHODS: Cells were cultured with varying concentrations of selenite, sulforaphane or the Ca2+ ionophore A23187 for 72-h, prior to assay of TrxR concentration and activity. Further cultures underwent prolonged (7-day) Se-depletion before selenoprotein measurement.
RESULTS: In Se-deficient cultures, neither Se, A23187 or sulforaphane affected TrxR2 concentration, while these treatments induced TrxR1 concentration (p<0.05). When co-incubated, optimal concentrations of Se (40 nM) and sulforaphane (4 microM) only modestly increased TrxR2 protein (approximately 1.3-fold), compared with TrxR1 (approximately 4-fold). In Se-deficient cells, TrxR activity was unaffected by sulforaphane or A23187. Prolonged Se-depletion caused a comparatively small reduction in TrxR2 (66% TrxR2 retained) against TrxR1 and glutathione peroxidase-1 activity (38% and 17% retained, respectively).
CONCLUSIONS: The relative resistance of TrxR2 to Se-deprivation and induction by sulforaphane and A23187 suggests TrxR2 lies near the top of the selenoprotein hierarchy in EAhy926 cells and exhibits near maximum expression under a range of culture conditions. In Se deficiency an inactive (possibly truncated) TrxR1 is produced in response to stimulus by sulforaphane and A23187. GENERAL SIGNIFICANCE: These observations underpin a likely critical antioxidant role for TrxR2 and TrxR1 in the endothelium.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19595745     DOI: 10.1016/j.bbagen.2009.07.001

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  9 in total

1.  ROS signaling by NOX4 drives fibroblast-to-myofibroblast differentiation in the diseased prostatic stroma.

Authors:  Natalie Sampson; Rafal Koziel; Christoph Zenzmaier; Lukas Bubendorf; Eugen Plas; Pidder Jansen-Dürr; Peter Berger
Journal:  Mol Endocrinol       Date:  2011-01-27

2.  Uptake and Utilization of Selenium from Selenoprotein P.

Authors:  Sumangala Shetty; John R Marsicano; Paul R Copeland
Journal:  Biol Trace Elem Res       Date:  2017-05-09       Impact factor: 3.738

3.  Characterization of the threshold for NAD(P)H:quinone oxidoreductase activity in intact sulforaphane-treated pulmonary arterial endothelial cells.

Authors:  Robert D Bongard; Gary S Krenz; Adam J Gastonguay; Carol L Williams; Brian J Lindemer; Marilyn P Merker
Journal:  Free Radic Biol Med       Date:  2011-01-14       Impact factor: 7.376

Review 4.  The role of the thioredoxin/thioredoxin reductase system in the metabolic syndrome: towards a possible prognostic marker?

Authors:  Alexey A Tinkov; Geir Bjørklund; Anatoly V Skalny; Arne Holmgren; Margarita G Skalnaya; Salvatore Chirumbolo; Jan Aaseth
Journal:  Cell Mol Life Sci       Date:  2018-01-11       Impact factor: 9.261

5.  Brain mitochondria from rats treated with sulforaphane are resistant to redox-regulated permeability transition.

Authors:  Tiffany Greco; Gary Fiskum
Journal:  J Bioenerg Biomembr       Date:  2010-12       Impact factor: 2.945

Review 6.  The emerging role of the thioredoxin system in angiogenesis.

Authors:  Louise L Dunn; Andrew M Buckle; John P Cooke; Martin K C Ng
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-08-26       Impact factor: 8.311

Review 7.  Therapeutic targeting of redox signaling in myofibroblast differentiation and age-related fibrotic disease.

Authors:  Natalie Sampson; Peter Berger; Christoph Zenzmaier
Journal:  Oxid Med Cell Longev       Date:  2012-10-22       Impact factor: 6.543

8.  N-methyl-D-aspartate receptor-dependent denitrosylation of neuronal nitric oxide synthase increase the enzyme activity.

Authors:  Zhong-Wei Qu; Wan-Ying Miao; Shu-Qun Hu; Chong Li; Xing-Li Zhuo; Yan-Yan Zong; Yong-Ping Wu; Guang-Yi Zhang
Journal:  PLoS One       Date:  2012-12-28       Impact factor: 3.240

9.  Redox signaling as a therapeutic target to inhibit myofibroblast activation in degenerative fibrotic disease.

Authors:  Natalie Sampson; Peter Berger; Christoph Zenzmaier
Journal:  Biomed Res Int       Date:  2014-02-20       Impact factor: 3.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.